| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Parthenolide | Acute Lymphoblastic Leukemia | 1 | PM | 37298119 | 📋 | Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies |
| Parthenolide | Breast Cancer | 2 | PM | 35525305 | 📋 | Parthenolide reverses the epithelial to mesenchymal transition process in breast cancer by targeting TGFbeta1: In vitro and in silico studies |
| Parthenolide | Breast Cancer | 1 | PM | 16579729 | 📋 | Antiproliferative Activities of Parthenolide and Golden Feverfew Extract Against Three Human Cancer Cell Lines |
| Parthenolide | Cancer | 2 | PM | 36427916 | 📋 | Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents |
| Parthenolide | Cancer | 1 | PM | 35203723 | 📋 | Parthenolide and Its Soluble Analogues: Multitasking Compounds with Antitumor Properties |
| Parthenolide | Cervical Cancer | 1 | PM | 38141074 | 📋 | Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway |
| Parthenolide | Colorectal Cancer | 2 | PM | 37337926 | 📋 | Parthenolide inhibits proliferation and invasion, promotes apoptosis, and reverts the cell-cell adhesion loss through downregulation of NF-κB pathway TNF-α-activated in colorectal cancer cells |
| Parthenolide | Colorectal Cancer | 1 | PM | 34030041 | 📋 | USP47 maintains the stemness of colorectal cancer cells and is inhibited by parthenolide |
| Parthenolide | Esophageal Cancer | 1 | PM | 32801767 | 📋 | Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF |
| Parthenolide | Gallbladder Cancer | 1 | PM | 38576937 | 📋 | Parthenolide induces gallbladder cancer cell apoptosis via MAPK signalling |
| Parthenolide | Gastric Cancer | 1 | PM | 38197565 | 📋 | Parthenolide induces ROS-dependent cell death in human gastric cancer cell |
| Parthenolide | Leukemia | 1 | PM | 34405014 | 📋 | Suppression Of Aberrant Activation Of NF-κB Pathway In Drug-resistant Leukemia Stem Cells Contributes To Parthenolide-potentiated Reversal Of Drug Resistance In Leukemia |
| Parthenolide | Liver Cancer | 3 | PM | 37741815 | 📋 | A novel SLC25A1 inhibitor, parthenolide, suppresses the growth and stemness of liver cancer stem cells with metabolic vulnerability |
| Parthenolide | Liver Cancer | 2 | PM | 36591540 | 📋 | Parthenolide induces rapid thiol oxidation that leads to ferroptosis in hepatocellular carcinoma cells |
| Parthenolide | Liver Cancer | 1 | PM | 36353537 | 📋 | Parthenolide and arsenic trioxide co-trigger autophagy-accompanied apoptosis in hepatocellular carcinoma cells |
| Parthenolide | Lung Cancer | 1 | PM | 32705224 | 📋 | Parthenolide inhibits human lung cancer cell growth by modulating the IGF‑1R/PI3K/Akt signaling pathway |
| Parthenolide | Lung Cancer | 2 | PM | 31868113 | 📋 | A Cocktail of Betulinic Acid, Parthenolide, Honokiol and Ginsenoside Rh2 in Liposome Systems for Lung Cancer Treatment |
| Parthenolide | Lung Cancer | 3 | PM | 30307334 | 📋 | The Combined Administration of Parthenolide and Ginsenoside CK in Long Circulation Liposomes With Targeted tLyp-1 Ligand Induce Mitochondria-Mediated Lung Cancer Apoptosis |
| Parthenolide | Lymphoma | 2 | PM | 37298119 | 📋 | Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies |
| Parthenolide | Lymphoma | 1 | PM | 34101920 | 📋 | Anticancer activities of parthenolide in primary effusion lymphoma preclinical models |
| Parthenolide | Multiple Myeloma | 2 | PM | 37298119 | 📋 | Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies |
| Parthenolide | Multiple Myeloma | 1 | PM | 21417826 | 📋 | The natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma |
| Parthenolide | Pancreatic Cancer | 1 | PM | 38474833 | 📋 | The Natural Product Parthenolide Inhibits Both Angiogenesis and Invasiveness and Improves Gemcitabine Resistance by Suppressing Nuclear Factor κB Activation in Pancreatic Cancer Cell Lines |
| Parthenolide | Renal Cell Carcinoma | 1 | PM | 33367934 | 📋 | Parthenolide inhibits the tumor characteristics of renal cell carcinoma |
| Parthenolide | Thyroid Cancer | 2 | PM | 37095470 | 📋 | Untargeted lipidomic analysis and network pharmacology for parthenolide treated papillary thyroid carcinoma cells |
| Parthenolide | Thyroid Cancer | 1 | PM | 35366876 | 📋 | Parthenolide leads to proteomic differences in thyroid cancer cells and promotes apoptosis |
